Intelligence Platform
Patents
Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10894966
Virus-based expression vectors and uses thereof
granted patentUS 10894077
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic
granted patentUS 10894073
Pinot noir grape products for nonalcoholic fatty liver disease and other uses
granted patentUS 10881653
Tricyclic compounds and their use in the treatment of cancer
granted patentUS 10881669
Inhibitors of the plasmodial surface anion channel as antimalarials
granted patentUS 10881722
Epizootic hemorrhagic disease vaccine
granted patentUS 10882886
Adeno-associated virus polynucleotides, polypeptides and virions
granted patentUS 10876003
Class of stable heptamethine cyanine fluorophores and biomedical applications thereof
granted patentUS 10876123
Chimeric antigen receptors targeting B-cell maturation antigen
granted patentUS 10875860
Azaindenoisoquinoline compounds and uses thereof
granted patentUS 10869865
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
granted patentUS 10869920
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine
granted patentUS 10870687
Anti-human papillomavirus 16 E7 T cell receptors
granted patentUS 10869856
Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
granted patentUS 10864252
Anti-SSX-2 T cell receptors and related materials and methods of use
granted patentUS 10864285
Methods for the diagnosis and treatment of SjΓΆgren's syndrome
granted patentUS 10865389
DNA vaccines against foot-and-mouth disease virus
granted patentUS 10858634
Vaccines and pharmaceutical compositions against foot-and-mouth disease virus
granted patentUS 10858633
Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modifi
granted patentUS 10849975
Multivalent vaccines for rabies virus and filoviruses
granted patentUS 10849912
Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands
granted patentUS 10849960
Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovaria
granted patentUS 10849970
Antibody evolution immunogens
granted patentUS 10844387
Chimeric antigen receptors targeting B-cell maturation antigen
granted